BioLineRx Ltd. (BLRX)
2.80
-0.01
(-0.36%)
USD |
NASDAQ |
Aug 24, 16:00
2.80
0.00 (0.00%)
After-Hours: 20:00
BioLineRx Price : 2.80 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 2.86 | 3.10 | 2.800 | 2.81 | 2691.00 |
| Aug 20, 2026 | 2.96 | 3.00 | 2.76 | 2.76 | 4269.00 |
| Aug 19, 2026 | 2.73 | 2.93 | 2.73 | 2.93 | 2414.00 |
| Aug 18, 2026 | 2.67 | 2.85 | 2.67 | 2.85 | 20401.00 |
| Aug 17, 2026 | 2.76 | 2.86 | 2.605 | 2.64 | 19701.00 |
| Aug 14, 2026 | 2.70 | 2.76 | 2.69 | 2.76 | 3076.00 |
| Aug 13, 2026 | 2.69 | 2.87 | 2.65 | 2.719 | 4892.00 |
| Aug 12, 2026 | 2.72 | 3.002 | 2.688 | 2.69 | 11292.00 |
| Aug 11, 2026 | 2.73 | 2.848 | 2.73 | 2.775 | 4591.00 |
| Aug 10, 2026 | 2.66 | 2.85 | 2.66 | 2.712 | 8719.00 |
| Aug 07, 2026 | 2.85 | 2.85 | 2.71 | 2.71 | 6692.00 |
| Aug 06, 2026 | 2.84 | 2.88 | 2.71 | 2.79 | 15644.00 |
| Aug 05, 2026 | 2.82 | 2.974 | 2.717 | 2.717 | 4642.00 |
| Aug 04, 2026 | 2.805 | 2.82 | 2.710 | 2.76 | 3960.00 |
| Aug 03, 2026 | 2.78 | 2.875 | 2.63 | 2.657 | 5068.00 |
| Jul 31, 2026 | 2.73 | 2.82 | 2.649 | 2.82 | 9653.00 |
| Jul 30, 2026 | 2.75 | 2.77 | 2.68 | 2.70 | 7123.00 |
| Jul 29, 2026 | 2.81 | 2.89 | 2.75 | 2.75 | 5796.00 |
| Jul 28, 2026 | 2.84 | 2.91 | 2.81 | 2.81 | 16045.00 |
| Jul 27, 2026 | 2.87 | 2.92 | 2.817 | 2.817 | 5005.00 |
| Jul 24, 2026 | 2.86 | 3.04 | 2.82 | 2.82 | 2696.00 |
| Jul 23, 2026 | 2.82 | 3.039 | 2.82 | 2.86 | 8019.00 |
| Jul 22, 2026 | 2.90 | 2.988 | 2.82 | 2.848 | 14717.00 |
| Jul 21, 2026 | 2.86 | 3.015 | 2.86 | 2.92 | 8859.00 |
| Jul 20, 2026 | 2.91 | 3.062 | 2.827 | 2.83 | 27859.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| XTL Biopharmaceuticals Ltd. | 2.53 |
| Kamada Ltd. | 8.42 |
| Can-Fite BioPharma Ltd. | 3.28 |
| Galmed Pharmaceuticals Ltd. | 4.02 |
| Revium Recovery, Inc. | 1.43 |
Price Related Metrics
| PS Ratio | 8.476 |
| PEG Ratio | -0.0014 |
| Price to Book Value | 0.7308 |
| Earnings Yield | -76.46% |
| Market Cap | 12.18M |
| PEGY Ratio | -0.0014 |